Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd.’s Net Profit Dropped 1.2% in First Quarter of 2023
Listen to the full version

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (上海神奇制药投资管理股份有限公司) (600613.SH) reported a net profit of 23.4 million yuan in the first quarter of 2023, down 1.2% year-on-year.
Meanwhile, the company posted 582.8 million yuan in revenue, down 0.9% year-on-year.
At the end of the reporting period, it had 3.2 billion yuan in total assets and 777.2 million yuan in total liabilities, with a liability-to-asset ratio of 24.5%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR